Zenoo Compliance Brief
Compliagence launches AI platform for perpetual audit readiness
Plus, ExThera Medical settles $6m healthcare fraud case, OFAC green-lights Lukoil asset sale talks, and UAE tightens AML and beneficial ownership standards.
19 March 2026 · 5 min read
Compliagence has gone live with an AI-native platform pitched at continuous compliance monitoring and controls design. The outfit, staffed by ex-Big Four and Fortune 500 operators, is targeting the perpetual audit-readiness gap most firms still wrestle with. Separately, a US medical device firm has resolved criminal charges, OFAC has licensed sanctions negotiations, and the UAE has raised the bar on AML and transparency rules. All the detail below.
In today's brief
- 1 Can AI-native compliance monitoring replace traditional gap analysis workflows for mid-market firms?
- 2 What ExThera's guilty plea reveals about CRO-level accountability in healthcare fraud schemes.
- 3 What does OFAC's Lukoil license mean for deal teams managing Russian asset disposals?
- 4 Do your virtual asset and gaming platform sanctions controls meet UAE's new integrated screening standard?
Subscribe to keep reading.
This content is free, but you must be subscribed to the Zenoo Compliance Brief to continue reading.
Free · Curated by compliance practitioners · Zero spam
Already a subscriber?